Analysis of the Global In Vitro Diagnostics Market

Slowing US and European Markets Demand Alignment with Global Market Needs

Regular Price: USD 4,950

Special Price USD 4,455

10% OFF

* Required Fields

Regular Price: USD 4,950

Special Price USD 4,455

PAY BY INVOICE

Be the first to review this product

Despite global economic and industry challenges, in vitro diagnostics (IVD) markets are growing robustly at double the rate of the global pharmaceutical industry. The global IVD market size was $47.30 billion in 2013; it is expected to reach $62.63 billion in 2017, at a compound annual growth rate of 7.3%. Because of stagnating mature markets, companies are heavily focused on globalization in emerging economies such as China and Brazil. This research service discusses the IVD segments of immunochemistry, point-of-care testing, molecular diagnostics, clinical microbiology, tissue diagnostics, hematology, hemostasis, and self-monitoring blood glucose.

Table of Contents

Executive SummaryExecutive SummaryExecutive Summary (continued)Executive Summary (continued)Scope and SegmentationKey Questions This Study Will AnswerMarket Engineering MeasurementsCEO’s PerspectiveMethodologyMarket OverviewMarket Overview—DefinitionsMarket SegmentationExternal Challenges: Drivers and Restraints—Total IVD MarketMarket DriversDrivers ExplainedDrivers Explained (continued)Drivers Explained (continued)Drivers Explained (continued)Market RestraintsRestraints ExplainedRestraints Explained (continued)Restraints Explained (continued)Restraints Explained (continued)Focus on Emerging Markets—Market DriversFocus on Emerging Markets—Market RestraintsForecasts and Trends—Total IVD MarketMarket Engineering MeasurementsMarket Engineering Measurements (continued)Total IVD Market—Revenue ForecastRevenue Forecast DiscussionMarket Share and Competitive Analysis— Total IVD MarketCompetitive Analysis—Market ShareMarket Share AnalysisCompetitive EnvironmentCompetitive Factors—Mergers & AcquisitionsImmunochemistry Segment BreakdownImmunochemistry Segment—OverviewImmunochemistry Segment—Market Engineering MeasurementsImmunochemistry Segment—Revenue ForecastImmunochemistry Segment—Revenue Forecast DiscussionCompetitive Analysis—Market ShareCompetitive Analysis—Market Share (continued)Immunochemistry Segment—Competitive EnvironmentImmunochemistry Segment—Installed BaseImmunochemistry Segment—Product AnalysisImmunochemistry Segment—Product Analysis (continued)Immunochemistry Segment—Product ListImmunochemistry Segment—Product List (continued)Immunochemistry Segment—Product List (continued)Immunochemistry Segment—Common TestsImmunochemistry Segment—Common Tests (continued)Self-monitoring Blood Glucose Segment BreakdownSMBG Segment—OverviewSMBG Segment—Market Engineering MeasurementsSMBG Segment—Revenue ForecastSMBG Segment—Revenue Forecast DiscussionCompetitive Analysis—Market ShareMarket Share Analysis SMBG Segment—Competitive EnvironmentSMBG Segment—Product ListPoint-of-care Testing Segment BreakdownPOCT Segment—OverviewPOCT Segment—Market Engineering MeasurementsPOCT Segment—Revenue ForecastPOCT Segment—Revenue Forecast DiscussionCompetitive Analysis—Market ShareMarket Share AnalysisPOCT Segment—Competitive EnvironmentMolecular Diagnostics Segment Breakdown Molecular Diagnostics Segment—Overview Molecular Diagnostics Segment—Overview (continued)Molecular Diagnostics Segment—Market Engineering MeasurementsMolecular Diagnostics Segment—Revenue ForecastMolecular Diagnostics Segment—Revenue Forecast DiscussionCompetitive Analysis—Market ShareMarket Share AnalysisMolecular Diagnostics Segment—Competitive EnvironmentMolecular Diagnostics Segment—TestsMolecular Diagnostics Segment—Product ListMolecular Diagnostics Segment—Product List (continued)Molecular Diagnostics Segment—Product List (continued)Molecular Diagnostics Segment—Product List (continued)Hematology Segment BreakdownHematology Segment—OverviewHematology Segment—Market Engineering MeasurementsHematology Segment—Revenue ForecastHematology Segment—Revenue Forecast DiscussionCompetitive Analysis—Market ShareMarket Share Analysis Hematology Segment—Competitive EnvironmentHematology Segment—Installed BaseHematology Segment—Installed Base (continued)Hematology Segment—Product ListHematology Segment—Product List (continued)Clinical Microbiology Segment BreakdownClinical Microbiology Segment—OverviewClinical Microbiology Segment—Market Engineering MeasurementsClinical Microbiology Segment—Revenue ForecastClinical Microbiology Segment—Revenue Forecast DiscussionCompetitive Analysis—Market ShareMarket Share Analysis Clinical Microbiology Segment—Competitive EnvironmentClinical Microbiology Segment—Technology TrendsHemostasis Segment BreakdownHemostasis Segment—OverviewHemostasis Segment—Market Engineering MeasurementsHemostasis Segment—Revenue ForecastHemostasis Segment—Revenue Forecast DiscussionCompetitive Analysis—Market ShareMarket Share AnalysisHemostasis Segment—Competitive EnvironmentHemostasis Segment—TestsHemostasis Segment—Product ListHemostasis Segment—Product List (continued)Tissue Diagnostics Segment BreakdownTissue Diagnostics Segment OverviewTissue Diagnostics Segment Overview (continued)Tissue Diagnostics Segment—Market Engineering MeasurementsTissue Diagnostics Segment—Revenue ForecastTissue Diagnostics Segment—Revenue Forecast by SubsegmentTissue Diagnostics Segment—Revenue Forecast DiscussionCompetitive Analysis—Market ShareCompetitive Analysis—Market Share (continued)Competitive StructureRegional BreakdownTotal IVD Market—Percent Revenue Forecast by RegionTotal IVD Market—Regional GrowthIVD Market—US Revenue ForecastIVD Market—Western Europe Revenue ForecastIVD Market—Asia-Pacific and China Revenue ForecastIVD Market—Brazil Revenue ForecastIVD Market—Eastern Europe Revenue ForecastIVD Market—Rest of World Revenue ForecastThe Last WordThe Last Word—Three Big PredictionsThe Last Word—DiscussionThe Last Word—Discussion (continued)Legal DisclaimerAppendixList of Other Companies—Total Market LevelList of Other Companies—Segment LevelList of Other Companies—US Tissue Diagnostics SegmentAssociated MultimediaAssociated Multimedia (continued)Market Engineering MethodologyLearn More—Next Steps




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 15-Nov-17

Region : North America

Release Date : 15-Nov-17

Region : North America

Release Date : 13-Nov-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.